Skip to content

Stephan Schmidt

2 papers in the library · 4 citations · publishing 2011-2016

Papers

Sort Most recent Most cited

Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice

Acta Pharmaceutica Sinica B August 6, 2016 Xi-Ling Jiang, Hong-Wu Shen, Donald E. Mager et al. 4 citations

We have shown recently that concurrent harmaline, a monoamine oxidase-A inhibitor (MAOI), potentiates serotonin (5-HT) receptor agonist 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)-induced hyperthermia. The objective of this study was to develop an integrated pharmacokinetic/pharmacodynamic (PK/PD) model to characterize and predict the thermoregulatory effects of such serotonergic drugs in...

Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.

British Journal of Clinical Pharmacology June 2011 Marieke Liem-Moolenaar, Peter de Boer, Maarten Timmers et al.

• The cholinergic system is important for different central nervous system functions, including memory, learning and attention. Scopolamine, a centrally active muscarinic antagonist, has been used to model dementia and to demonstrate the pharmacological effects of cholinergic drugs, but for most effects the concentration-effect relationships are unknown. • We determined the...